Tomographic ventilation/perfusion lung scintigraphy in the monitoring of the effect of treatment in pulmonary embolism: Serial follow-up over a 6-month period

Nuclear Medicine Communications

Volumn 32, Issue 6, 2011, Pages 508-514

  Begic, Amela ^a   Jögi, Jonas ^c   Hadziredzepovic, Amra ^b   Kucukalic Selimović, Elma ^a   Begovic Hadzimuratovic, Sadzida ^a   Bajc, Marika ^c  

^a Clinical Center   (Germany)

^b University of East Sarajevo   (Bosnia and Herzegovina)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Follow up; lung scintigraphy; pulmonary embolism; Technegas; ventilation perfusion single photon emission computed tomography

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; MACROSALB TC 99M; TECHNEGAS; TECHNESCAN LYOMAA; UNCLASSIFIED DRUG;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HUMAN; LUNG EMBOLISM; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT DURATION; VENTILATION PERFUSION SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANTICOAGULANTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LABORATORIES; LUNG; MALE; MIDDLE AGED; PULMONARY EMBOLISM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; VENTILATION-PERFUSION RATIO;

EID: 79955555751     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328344dfd5     Document Type: Article

References (40)

1. Torbicki A, Perrier A, Konstantinides S, Agnelli G, Galie N, Pruszczyk P, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008; 29:2276-2315.
2. Hildner FJ, Ormond RS. Accuracy of the clinical diagnosis of pulmonary embolism. JAMA 1967; 202:567-570.
3. Stein PD, Terrin ML, Hales CA, Palevsky HI, Saltzman HA, Thompson BT, et al. Clinical, laboratory, roentgenographic, and electrocardiographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease. Chest 1991; 100:598-603.
4. Gray HW. The natural history of venous thromboembolism: impact on ventilation/perfusion scan reporting. Semin Nucl Med 2002; 32:159-172. (Pubitemid 34803589)
5. Bajc M, Neilly JB, Miniati M, Schuemichen C, Meignan M, Jonson B. EANM guidelines for ventilation/perfusion scintigraphy: Part 2. Algorithms and clinical considerations for diagnosis of pulmonary emboli with V/P(SPECT) and MDCT. Eur J Nucl Med Mol Imaging 2009; 36:1528-1538.
6. Bajc M, Bitzen U, Olsson B, Perez de Sa V, Palmer J, Jonson B. Lung ventilation/perfusion SPECT in the artificially embolized pig. J Nucl Med 2002; 43:640-647. (Pubitemid 34507116)
7. Gutte H, Mortensen J, Jensen CV, Von der Recke P, Petersen CL, Kristoffersen US, et al. Comparison of V/Q SPECT and planar V/Q lung scintigraphy in diagnosing acute pulmonary embolism. Nucl Med Commun 2010; 31:82-86.
8. Bajc M, Olsson B, Palmer J, Jonson B. Ventilation/perfusion SPECT for diagnostics of pulmonary embolism in clinical practice. J Intern Med 2008; 264:379-387.
9. Miles S, Rogers KM, Thomas P, Soans B, Attia J, Abel C, et al. A comparison of single-photon emission CT lung scintigraphy and CT pulmonary angiography for the diagnosis of pulmonary embolism. Chest 2009; 136:1546-1553.
10. Reinartz P, Wildberger JE, Schaefer W, Nowak B, Mahnken AH, Buell U. Tomographic imaging in the diagnosis of pulmonary embolism: a comparison between V/Q lung scintigraphy in SPECT technique and multislice spiral CT. J Nucl Med 2004; 45:1501-1508. (Pubitemid 47618504)
11. Leblanc M, Leveillee F, Turcotte E. Prospective evaluation of the negative predictive value of V/Q SPECTusing 99mTc-Technegas. Nucl Med Commun 2007; 28:667-672. (Pubitemid 47067055)
12. Tunariu N, Gibbs SJ,Win Z, Gin-Sing W, Graham A, Gishen P, et al. Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med 2007; 48:680-684. (Pubitemid 47604965)
13. Jögi J, Jonson B, Ekberg M, Bajc M. Ventilation-perfusion SPECTwith 99mTc- DTPA versus Technegas: a head-to-head study in obstructive and nonobstructive disease. J Nucl Med 2010; 51:735-741.
14. Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet 1960; 1:1309-1312.
15. British Thoracic Society Standards of Care Committee Pulmonary Embolism Guideline Development Group. British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax 2003; 58:470-483.
16. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133:454S-545S. (Pubitemid 351892971)
17. Baglin TP, Keeling DM, Watson HG. Guidelines on oral anticoagulation (warfarin): third edition-2005 update. Br J Haematol 2006; 132:277-285. (Pubitemid 43381534)
18. Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento R, et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1626 patients. Haematologica 2007; 92:199-205.
19. Agnelli G, Becattini C. Treatment of DVT: how long is enough and how do you predict recurrence. J Thromb Thrombolysis 2008; 25:37-44. doi:10.1007/s11239-007-0103-z.
20. Garcia D. Duration of anticoagulant therapy for patients with venous thromboembolism. Thromb Res 2008; 123 (Suppl 1):S62-S64.
21. Houman Fekrazad M, Lopes RD, Stashenko GJ, Alexander JH, Garcia D. Treatment of venous thromboembolism: guidelines translated for the clinician. J Thromb Thrombolysis 2009; 28:270-275. doi:10.1007/s11239- 009-0374-7.
22. Olsson CG, Bitzen U, Olsson B, Magnusson P, Carlsson MS, Jonson B, et al. Outpatient tinzaparin therapy in pulmonary embolism quantified with ventilation/perfusion scintigraphy. Med Sci Monit 2006; 12:PI9-PI13. (Pubitemid 43200954)
23. Bajc M, Neilly JB, Miniati M, Schuemichen C, Meignan M, Jonson B. EANM guidelines for ventilation/perfusion scintigraphy: Part 1. Pulmonary imaging with ventilation/perfusion single photon emission tomography. Eur J Nucl Med Mol Imaging 2009; 36:1356-1370.
24. Palmer J, Bitzen U, Jonson B, Bajc M. Comprehensive ventilation/perfusion SPECT. J Nucl Med 2001; 42:1288-1294. (Pubitemid 32717851)
25. Bajc M, Olsson CG, Olsson B, Palmer J, Jonson B. Diagnostic evaluation of planar and tomographic ventilation/perfusion lung images in patients with suspected pulmonary emboli. Clin Physiol Funct Imaging 2004; 24:249-256. (Pubitemid 39359393)
26. Goldhaber SZ, Haire WD, Feldstein ML, Miller M, Toltzis R, Smith JL, et al. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 1993; 341:507-511. (Pubitemid 23066083)
27. Kearon C. Natural history of venous thromboembolism. Circulation 2003; 107:I22-I30. (Pubitemid 41289268)
28. The Urokinase Pulmonary Embolism Trial. A national cooperative study: perfusion lung scanning. Circulation 1973; 47:II46-II50.
29. Hall RJ, Sutton GC, Kerr IH. Long-term prognosis of treated acute massive pulmonary embolism. Br Heart J 1977; 39:1128-1134. (Pubitemid 8191719)
30. Riedel M, Stanek V,Widimsky J, Prerovsky I. Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest 1982; 81:151-158. (Pubitemid 12165545)
31. Miniati M, Monti S, Bottai M, Scoscia E, Bauleo C, Tonelli L, et al. Survival and restoration of pulmonary perfusion in a long-term follow-up of patients after acute pulmonary embolism. Medicine (Baltimore) 2006; 85:253-262. (Pubitemid 44401458)
32. Secker Walker RH, Goodwin J, Jackson JA. Resolution of pulmonary embolism. Br Med J 1970; 4:135-139.
33. Wartski M, Collignon MA. Incomplete recovery of lung perfusion after 3 months in patients with acute pulmonary embolism treated with antithrombotic agents. THESEE Study Group. Tinzaparin ou Heparin Standard: Evaluation dans l'Embolie Pulmonaire Study. J Nucl Med 2000; 41:1043-1048. (Pubitemid 30396655)
34. Winebright JW, Gerdes AJ, Nelp WB. Restoration of blood flow after pulmonary embolism. Arch Intern Med 1970; 125:241-247.
35. Hvid-Jacobsen K, Fogh J, Nielsen SL, Thomsen HS, Hartling OJ. Scintigraphic control of pulmonary embolism. Eur J Nucl Med 1988; 14:71-72.
36. The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 1990; 263:2753-2759.
37. Collaborative Study by the PIOPED Investigators. Tissue plasminogen activator for the treatment of acute pulmonary embolism. Chest 1990; 97:528-533.
38. Research Committee of the British Thoracic Society. Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. Lancet 1992; 340:873-876.
39. Roach PJ, Bailey DL, Schembri GP. Reinventing ventilation/perfusion lung scanning with SPECT. Nucl Med Commun 2008; 29:1023-1025.
40. Jögi J, Palmer J, Jonson B, Bajc M. Heart failure diagnostics based on ventilation/perfusion single photon emission computed tomography pattern and quantitative perfusion gradients. Nucl Med Commun 2008; 29:666-673.